Abdom Radiol (NY)
- ZHENG X, Shen F, Chen W, Ren W, et al
Integrated pretreatment diffusion kurtosis imaging and serum squamous cell
carcinoma antigen levels: a biomarker strategy for early assessment of
radiotherapy outcomes in cervical cancer.
Abdom Radiol (NY). 2024 Mar 27. doi: 10.1007/s00261-024-04270.
- ZHANG Y, Hu Y, Zhao S, Xu S, et al
Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by
determining the metabolic and radiomic heterogeneity of primary tumors based on
(18)F-FDG PET/CT.
Abdom Radiol (NY). 2024 Mar 25. doi: 10.1007/s00261-024-04226.
ACS Appl Mater Interfaces
- GOSECKA M, Gosecki M, Ziemczonek P, Urbaniak M, et al
Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms
Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and
Combination Therapy.
ACS Appl Mater Interfaces. 2024;16:14605-14625.
Adv Sci (Weinh)
- YUAN L, Jiang H, Jia Y, Liao Y, et al
Fatty Acid Oxidation Supports Lymph Node Metastasis of Cervical Cancer via
Acetyl-CoA-Mediated Stemness.
Adv Sci (Weinh). 2024 Mar 23:e2308422. doi: 10.1002/advs.202308422.
- HU B, Wang R, Wu D, Long R, et al
A Promising New Model: Establishment of Patient-Derived Organoid Models Covering
HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers.
Adv Sci (Weinh). 2024;11:e2302340.
Anticancer Res
- AOSHIKA T, Noda SE, Abe T, Kumazaki YU, et al
Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based
Brachytherapy for Cervical Cancer.
Anticancer Res. 2024;44:1583-1589.
Asian Pac J Cancer Prev
- CHANGADE JV, Thanvi H, Raut C, Chavan M, et al
In vitro Evaluation of Anti-Cancer Potential of Different Solvent Extracts
Derived from Clerodendrum Infortunatum Linn against Cervical Cancer.
Asian Pac J Cancer Prev. 2024;25:1065-1075.
- SHAMSI U, Zahid F, Abdul Jabbar AB, Musharraf MD, et al
Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention
of Cervical Cancer in Pakistan: A Cross-Sectional Study.
Asian Pac J Cancer Prev. 2024;25:813-820.
- PAL D, Sahoo BK, Taywade M, Maji S, et al
Evidence of Knowledge, Attitude, and Practice Regarding Human Papilloma Virus
Vaccination at the Community Level in India: A Systematic Review and
Meta-analysis.
Asian Pac J Cancer Prev. 2024;25:793-800.
- PATIL-TAKBHATE BR
Cervical Cancer Screening Revolution: Advancements with Confocal Endomicroscopy.
Asian Pac J Cancer Prev. 2024;25:723-724.
Biomed Res Int
- INTERNATIONAL BR
Retracted: LINC00707 Promotes Cell Proliferation in Cervical Cancer via the
miR-374c-5p/SDC4 Axis.
Biomed Res Int. 2024;2024:9769120.
BMC Cancer
- NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
Positivity rates, trends and experiences of health workers on human
papillomavirus screened using genexpert in Uganda: a three-year retrospective
cohort study.
BMC Cancer. 2024;24:375.
- LI X, Zhao Y, Xiang F, Zhang X, et al
Evaluation of the diagnostic performance of colposcopy in the detection of
cervical high-grade squamous intraepithelial lesions among women with
transformation zone type 3.
BMC Cancer. 2024;24:381.
BMC Infect Dis
- AKAKPO PK, Imbeah EG, Ulzen-Appiah K, Darkwa-Abrahams A, et al
The distribution of hrHPV genotypes among cervical cancer cases diagnosed across
Ghana: a cross-sectional study.
BMC Infect Dis. 2024;24:356.
BMC Womens Health
- LALANDE E, Clarke H, Undurraga M, Nguyen VQH, et al
Knowledge of cytology results affects the performance of colposcopy: a crossover
study.
BMC Womens Health. 2024;24:189.
Brachytherapy
- ROMANO KD, Petroni G, Ward K, Zheng W, et al
A randomized trial evaluating a novel hydrogel packing system compared to
standard packing during image-guided high-dose rate brachytherapy boost for
cervical cancer.
Brachytherapy. 2024 Mar 21:S1538-4721(24)00035.
- PARIKH S, Zhang Y, Sherwani Z, Kumar R, et al
Impact of the COVID-19 pandemic on brachytherapy and cancer patient outcomes: A
systematic review.
Brachytherapy. 2024;23:141-148.
- OWRANGI A, Medrano A, Gao Y, Kazemifar S, et al
Definitive radiation for advanced cervix cancer is not associated with vaginal
shortening-a prospective vaginal length and dose correlation.
Brachytherapy. 2024;23:136-140.
- MANZAR GS, Alam MBE, Lynn EJ, Karpinets TV, et al
Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire
during chemoradiation and after brachytherapy.
Brachytherapy. 2024;23:123-135.
- TAKATSU J, Murakami N, Muramoto Y, Karino T, et al
Safe dose escalation and reduction of the fraction number of uterine cervical
brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A
planning study.
Brachytherapy. 2024;23:115-122.
Cancer
- MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
Significance of HIV status in cervical cancer patients receiving curative
chemoradiation therapy, definitive radiation alone, or palliative radiation in
Botswana.
Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
- LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al
Factors contributing to differences in cervical cancer screening in rural and
urban community health centers.
Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265.
Cancer Epidemiol Biomarkers Prev
- KROON KR, Bogaards JA, Heideman DA, Meijer CJ, et al
Colposcopy referral and CIN3+ risk of human papillomavirus genotyping strategies
in cervical cancer screening.
Cancer Epidemiol Biomarkers Prev. 2024.
Cancer Treat Res Commun
- TANIM MTH, Nath SD, Khan SF, Khan A, et al
Transcriptomes of cervical cancer provide novel insights into dysregulated
pathways, potential therapeutic targets, and repurposed drugs.
Cancer Treat Res Commun. 2024;39:100808.
Cancers (Basel)
- MOREAU M, Keno LS, China D, Mao S, et al
Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in
Cervical Cancer Treatment.
Cancers (Basel). 2024;16:1212.
- PHILLIPS V, Franco Montoya D, Adams EK
Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase
Female Breast and Cervical Cancer Screens: A Systematic Review.
Cancers (Basel). 2024;16:1134.
- BIANCHI T, Grassi T, Di Martino G, Negri S, et al
Low-Volume Metastases in Cervical Cancer: Does Size Matter?
Cancers (Basel). 2024;16:1107.
Cell Biochem Biophys
- TANG XH, Zhao TN, Guo L, Liu XY, et al
Cell-Cycle-related Protein Centromere Protein F Deficiency Inhibits Cervical
Cancer Cell Growth by Inducing Ferroptosis Via Nrf2 Inactivation.
Cell Biochem Biophys. 2024 Mar 27. doi: 10.1007/s12013-024-01251.
Clin Appl Thromb Hemost
- CHENG S, Gao H, Li Y, Shi X, et al
Analysis of Risk Factors of Postoperative Lower Extremity Deep Venous Thrombosis
in Patients With Cervical Cancer.
Clin Appl Thromb Hemost. 2024;30:10760296241240747.
Crit Rev Oncol Hematol
- SNIADECKI M, Guani B, Jaworek P, Klasa-Mazurkiewicz D, et al
Tertiary prevention strategies for micrometastatic lymph node cervical cancer: A
systematic review and a prototype of an adapted model of care.
Crit Rev Oncol Hematol. 2024 Mar 23:104329.
Cureus
- FADL J, Aljuhani RA, Albog YH, Khraisat AF, et al
Role of microRNA in Sex Steroid Hormones Signaling and Its Effect in Regulation
of Endometrial, Ovarian, and Cervical Cancer: A Literature Review.
Cureus. 2024;16:e54773.
- ZHANG N, Guo MF
Granulocyte-Macrophage Colony-Stimulating Factor in Combination With
Chemoradiation for Recurrent or Metastatic Cervical Cancer.
Cureus. 2024;16:e54573.
Diagnostics (Basel)
- KAYA TERZI N, Yulek O
Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer
Screening: Implications for Diagnosis and Follow-Up Strategies.
Diagnostics (Basel). 2024;14:611.
Discov Oncol
- YAN K, Hu C, Cheng Y, Zheng L, et al
Circ_0020460 drives tumorigenesis in cervical cancer through miR-485-3p sponging.
Discov Oncol. 2024;15:88.
Environ Mol Mutagen
- PEREIRA IOA, Silva NNT, Lima AA, da Silva GN, et al
Qualitative and quantitative changes in mitochondrial DNA associated with
cervical cancer: A comprehensive review.
Environ Mol Mutagen. 2024 Mar 24. doi: 10.1002/em.22591.
Eur J Cancer Prev
- DOMBROWSKI C, Bourgain C, Ma Y, Meiwald A, et al
An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV
primary compared to HR-HPV and liquid-based cytology co-testing.
Eur J Cancer Prev. 2024;33:262-270.
Expert Rev Anticancer Ther
- CAROBELI LR, Santos ABC, Martins LBM, Damke E, et al
Recent advances in photodynamic therapy combined with chemotherapy for cervical
cancer: a systematic review.
Expert Rev Anticancer Ther. 2024 Mar 28. doi: 10.1080/14737140.2024.2337259.
Front Biosci (Landmark Ed)
- LI C, Li Q, Li L, Sun S, et al
The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship
with Proliferation and Apoptosis of Cervical Cancer.
Front Biosci (Landmark Ed). 2024;29:97.
Front Cell Infect Microbiol
- LOONEN AJM, Verhagen F, Luijten-de Vrije I, Lentjes-Beer M, et al
Vaginal dysbiosis seems associated with hrHPV infection in women attending the
Dutch Cervical Cancer Screening Program.
Front Cell Infect Microbiol. 2024;14:1330844.
- GONCALVES-NOBRE JG, Matos A, Carreira M, Santos AC, et al
The interplay between HPV, other Sexually Transmissible Infections and genital
microbiome on cervical microenvironment (MicroCervixHPV study).
Front Cell Infect Microbiol. 2024;13:1251913.
- ALBANO C, Biolatti M, Mazibrada J, Pasquero S, et al
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable
target for HPV-associated cervical cancer.
Front Cell Infect Microbiol. 2024;14:1359367.
Front Immunol
- LI T, Zhang W, Niu M, Wu Y, et al
STING agonist inflames the cervical cancer immune microenvironment and overcomes
anti-PD-1 therapy resistance.
Front Immunol. 2024;15:1342647.
- KOUSAR K, Naseer F, Abduh MS, Anjum S, et al
Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus
encapsulated in thiolated chitosan for sustained release in cervical cancer: a
targeted immunotherapy approach.
Front Immunol. 2024;15:1391710.
Front Oncol
- ZHAO W, Li Q, Wen S, Li Y, et al
Novel biomarkers of inflammation-associated immunity in cervical cancer.
Front Oncol. 2024;14:1351736.
- BELLOTTI JA, Gutierres IG, Furtado YL, Patury P, et al
Surgical, oncologic, and obstetric outcomes of radical trachelectomy in
early-stage cervical cancer: results from a retrospective cohort study at Brazil
National Cancer Institute.
Front Oncol. 2024;14:1267625.
Genes (Basel)
- ALMOROX L, Antequera L, Rojas I, Herrera LJ, et al
Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
Genes (Basel). 2024;15:312.
Gynecol Oncol
- CHOI KH, Lee HC, Kim YS, Park W, et al
Diagnostic assessments and treatment results of well-differentiated gastric-type
adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter
retrospective analysis of KROG 22-03 study.
Gynecol Oncol. 2024;182:45-50.
Gynecol Oncol Rep
- BABAYAN LM, Bouts C, Guntupalli S, Marjon NA, et al
Exploring tisotumab vedotin in recurrent cervical cancer: A case series including
an HPV-independent gastric type adenocarcinoma.
Gynecol Oncol Rep. 2024;52:101356.
Harm Reduct J
- HINKES S, Ciraldo K, Kobetz E, Bartholomew TS, et al
Opportunities for cancer prevention at syringe services programs: acceptability
of HPV self-sampling and vaccination among people who inject drugs.
Harm Reduct J. 2024;21:70.
Int J Clin Oncol
- KANG HB, Kim SH, Lee JH, Lee HC, et al
MRI-based volumetric tumor parameters before and during chemoradiation predict
tumor recurrence and patient survival in locally advanced cervical cancer: a
subgroup analysis of a phase II prospective trial.
Int J Clin Oncol. 2024 Mar 26. doi: 10.1007/s10147-024-02490.
- NAKAI H, Higashi T, Kakuwa T, Matsumura N, et al
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality
from 1981 to 2021.
Int J Clin Oncol. 2024;29:363-371.
Int J Environ Res Public Health
- LOCKWOOD L, Ju X, Sethi S, Hedges J, et al
Knowledge and Awareness of HPV, the HPV Vaccine and Cancer-Related HPV Types
among Indigenous Australians.
Int J Environ Res Public Health. 2024;21:307.
- COSTA AS, Baracat EC, Junior JMS, Sorpreso ICE, et al
Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period
Caused by the SARS-CoV-2 Virus: Ecological Study.
Int J Environ Res Public Health. 2024;21:303.
Int J Mol Sci
- LEE WT, Wu PY, Cheng YM, Huang YF, et al
Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and
Significance in Oncology.
Int J Mol Sci. 2024;25:3191.
Int J Womens Health
- BALUWA PC, Moyo RC, Baluwa MA, Nyirenda L, et al
Barriers Associated with Adherence to Cervical Cancer Screening Among Women
Living with HIV in Nkhatabay District, Malawi: A Mixed-Methods Study.
Int J Womens Health. 2024;16:491-507.
Ir J Med Sci
- ROURKE M, Fitzpatrick P, Popoola O, Boms R, et al
The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old
women attending cervical screening in Ireland.
Ir J Med Sci. 2024;193:665-668.
J Appl Clin Med Phys
- WANG X, Chang Y, Pei X, Xu XG, et al
A prior-information-based automatic segmentation method for the clinical target
volume in adaptive radiotherapy of cervical cancer.
J Appl Clin Med Phys. 2024 Mar 28:e14350. doi: 10.1002/acm2.14350.
J Biophotonics
- DEO BS, Sah AN, Shukla S, Pandey K, et al
Cervical pre-cancer classification using entropic features and CNN: In vivo
validation with a handheld fluorescence probe.
J Biophotonics. 2024;17:e202300363.
J Cell Mol Med
- YING L, Kong L, Qiu X, Cheng A, et al
A novel mitochondria-related core gene signature to predict the prognosis and
evaluate tumour microenvironment in CESC single-cell validation.
J Cell Mol Med. 2024;28:e18265.
J Educ Health Promot
- GHASEMI-GUJANI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
Development of mobile application for cervical cancer screening in women:
Protocol of a multi-phase study.
J Educ Health Promot. 2024;13:5.
J Gynecol Oncol
- LIU Y, Xin W, Wang P, Ji M, et al
Intraoperative frozen section pathology of vaginal margin in radical hysterectomy
on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer:
study protocol for a multicenter randomized controlled trial.
J Gynecol Oncol. 2024 Mar 11. doi: 10.3802/jgo.2024.
- CHO EH, Park MS, Woo HY, Park H, et al
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical
cancer screening.
J Gynecol Oncol. 2024 Mar 15. doi: 10.3802/jgo.2024.
J Infect Public Health
- ALHERZ FA, Alamri AA, Aljbreen A, Alwallan N, et al
Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the
HPV vaccine among parents of daughters in Riyadh, Saudi Arabia.
J Infect Public Health. 2024;17:789-794.
J Interprof Care
- GUAN P, Han X, Li D, Liao B, et al
Effect of nurse-physician collaboration on the incidence of complications,
negative emotions and quality of life in cervical cancer patients: a randomized
controlled study.
J Interprof Care. 2024 Mar 25:1-9. doi: 10.1080/13561820.2024.2327621.
J Low Genit Tract Dis
- SOEGAARD-ANDERSEN E, Frandsen AP, Sandahl P
Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop
Electrosurgical Excision Procedure Strategy: An Observational Study.
J Low Genit Tract Dis. 2024;28:149-152.
- CLARKE MA, Wentzensen N, Perkins RB, Garcia F, et al
Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals
Testing Positive for Human Papillomavirus.
J Low Genit Tract Dis. 2024;28:124-130.
- GRACA J, Preti M, Pollano B, Vieira-Baptista P, et al
Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk
After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
J Low Genit Tract Dis. 2024;28:131-136.
J Med Microbiol
- KAMBLE A, Naik S, Talathi M, Jadhav D, et al
Exploring the diversity of vaginal microbiota between healthy women and cervical
cancer patients in India.
J Med Microbiol. 2024;73.
J Med Virol
- KIM M, Kim E
Effective vaccination strategies for human papillomavirus (HPV) infection and
cervical cancer based on the mathematical model with a stochastic process.
J Med Virol. 2024;96:e29558.
J Nucl Med
- COLLARINO A, Feudo V, Pasciuto T, Florit A, et al
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in
Locally Advanced Cervical Cancer?
J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044.
J Radiat Res
- IKUSHIMA H, Ii N, Noda SE, Masui K, et al
Patterns of care for brachytherapy in Japan.
J Radiat Res. 2024;65:168-176.
Lancet
- TEWARI KS, Monk BJ
Immunotherapy plus chemoradiotherapy in cervical cancer management.
Lancet. 2024 Mar 20:S0140-6736(24)00468-9. doi: 10.1016/S0140-6736(24)00468.
- LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or
placebo for newly diagnosed, high-risk, locally advanced cervical cancer
(ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical
trial.
Lancet. 2024 Mar 20:S0140-6736(24)00317-9. doi: 10.1016/S0140-6736(24)00317.
Life (Basel)
- JUNG L, Klamminger GG, Bier B, Eltze E, et al
From Satirical Poems and Invisible Poisons to Radical Surgery and Organized
Cervical Cancer Screening-A Historical Outline of Cervical Carcinoma and Its
Relation to HPV Infection.
Life (Basel). 2024;14:307.
Matern Child Health J
- WANG S, Ren W, Zhang B, Chen M, et al
Knowledge, Attitude, and Uptake of Human Papillomavirus (HPV) Vaccination among
Chinese Female Adults: A National Cross-sectional Web-Based Survey Based on a
Large E-commerce Platform.
Matern Child Health J. 2024;28:746-757.
Med Oncol
- KRISHNAMOORTHY S, Sabanayagam R, Periyasamy L, Muruganantham B, et al
Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance
and migration of cervical carcinoma cells.
Med Oncol. 2024;41:89.
Medicina (Kaunas)
- VITKAUSKAITE A, Urboniene D, Celiesiute J, Jariene K, et al
Expression of Inflammation Depending on the Stage of Cervical Cancer.
Medicina (Kaunas). 2024;60:349.
- SCHETTINO MT, Preti EP, Vietri V, Agrillo N, et al
The Role of beta1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of
Progression to Cervical Carcinoma in HPV-Associated Lesions.
Medicina (Kaunas). 2024;60:364.
MethodsX
- CHAUHAN R, Goel A, Alankar B, Kaur H, et al
Predictive modeling and web-based tool for cervical cancer risk assessment: A
comparative study of machine learning models.
MethodsX. 2024;12:102653.
O G Open
- HARPER DM, Yu TM, Fendrick AM
Lives Saved Through Increasing Adherence to Follow-Up After Abnormal Cervical
Cancer Screening Results.
O G Open. 2024;1:e001.
Obstet Gynecol
- TROISI R, Bertrand K, Hatch EE, Strohsnitter WC, et al
An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous
Intraepithelial Lesions of the Lower Genital Tract.
Obstet Gynecol. 2024;143:603-606.
Obstet Gynecol Sci
- WONGPRATATE M, Bumrungthai S
Cervical cancer in Thailand: 2023 update.
Obstet Gynecol Sci. 2024 Mar 25. doi: 10.5468/ogs.23277.
Pan Afr Med J
- AMORHA KC, Ozota GO, Ndunwere MO, Anyaji UL, et al
Knowledge, attitudes, and practices of adolescent girls regarding cervical
cancer: a cross-sectional study in Enugu State, Nigeria.
Pan Afr Med J. 2024;47:17.
- ZRAIDI M, Ibriz M
[The timeline of the screening and treatment strategy of intraepithelial
neoplasia of the uterine cervix adopted in Morocco].
Pan Afr Med J. 2024;47:13.
Pharmaceuticals (Basel)
- GARCIA-ROCHA R, Monroy-Garcia A, Vazquez-Cruz AL, Marin-Aquino LA, et al
Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by
Increasing PD-L1 Expression and TGF-beta Production through Its Interaction with
A(2A)R/A(2B)R.
Pharmaceuticals (Basel). 2024;17:397.
Photodiagnosis Photodyn Ther
- GILYADOVA AV, Ishchenko AA, Samoilova SV, Shiryaev AA, et al
Comparative study of treatment efficacy in severe intraepithelial squamous cell
lesions and preinvasive cervical cancer by conization and chlorin e6-mediated
fluorescence-assisted systemic photodynamic therapy.
Photodiagnosis Photodyn Ther. 2024;46:104060.
Phys Med Biol
- GAO Y, Gonzalez Y, Nwachukwu C, Albuquerque K, et al
Predicting treatment plan approval probability for high-dose-rate brachytherapy
of cervical cancer using adversarial deep learning.
Phys Med Biol. 2024 Mar 27. doi: 10.1088/1361-6560/ad3880.
Postepy Dermatol Alergol
- POPOVIC A, Bojic MD, Bojic M, Vukmirovic F, et al
Cutaneous metastases of cervical cancer: a rare entity and possible mechanisms of
dissemination.
Postepy Dermatol Alergol. 2024;41:136-138.
Prev Med Rep
- BURDIER FR, Waheed DE, Nedjai B, Steenbergen RDM, et al
DNA methylation as a triage tool for cervical cancer screening - A meeting
report.
Prev Med Rep. 2024;41:102678.
Qual Life Res
- TAAVELA K, Eriksson T, Huhtala H, Bly A, et al
The quality of life of frequently vs. infrequently screened HPV vaccinated women.
Qual Life Res. 2024;33:941-949.
Reprod Health
- ELISSA N, Charbel H, Marly A, Ingrid N, et al
Knowledge and perception of HPV vaccination among Lebanese mothers of children
between nine and 17 years old.
Reprod Health. 2024;21:40.
Reprod Sci
- DUTTA P, Pal D, Sultana F, Mandal RK, et al
Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed
During the Development of Chemo-tolerance: Clinical Implications.
Reprod Sci. 2024;31:1122-1138.
Rom J Morphol Embryol
- VOIDAZAN TS, Budianu MA, Cotoi OS, Turdean SG, et al
The importance of combined HPV and CINtec(R) PLUS genotyping testing for p16 in
women with cervical squamous cell carcinoma.
Rom J Morphol Embryol. 2024;65:99-105.
S Afr Med J
- OOKO F
Ensuring access to palliative care for cervical cancer patients.
S Afr Med J. 2023;114:3-4.
Virology
- LE VN, Le VNB, Hoang XS, Le VD, et al
Distribution of human papillomavirus among Vietnamese women with cervical cancer
and unusual genetic variability of HPV16.
Virology. 2024;594:110058.
Viruses
- HERNANDEZ-SILVA CD, Ramirez de Arellano A, Pereira-Suarez AL, Ramirez-Lopez IG, et al
HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and
Effect of Vaccination in Latin American Women.
Viruses. 2024;16:327.
World J Oncol
- WARLI SM, Tala MRZ, Wijaya WS
Predictive Factors of Successful Double J Stent Insertion Among Advanced Cervical
Cancer Patients.
World J Oncol. 2024;15:239-245.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016